Your session is about to expire
← Back to Search
Medical Device
Aluvra™ for Acid Reflux (NECTAR Trial)
N/A
Waitlist Available
Research Sponsored by Impleo Medical Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
NECTAR Trial Summary
This trial will test if Aluvra is safe and effective for treating GERD.
NECTAR Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Efficacy of Aluvra- Esophageal PH
Efficacy of Aluvra- GERD HRQL
NECTAR Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Aluvra™Experimental Treatment1 Intervention
Endoscopic injection of bulking agent (Aluvra) to the lower esophageal sphincter
Group II: SalinePlacebo Group1 Intervention
Endoscopic injection of saline
Find a Location
Who is running the clinical trial?
Impleo Medical Inc.Lead Sponsor
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger